Same Cancer Drugs, New Applications
The word of the week at the world's largest cancer meeting is "incremental." Some of the most notable data presented during the first two days of the annual American Society of Clinical Oncology (ASCO) meeting, June 1-5 in Chicago, was on new uses for existing drugs, rather than promising medicines still in the pipeline.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.